CVS vs HUM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

CVS

37.4
AI Score
VS
HUM Wins

HUM

40.0
AI Score

Investment Advisor Scores

CVS

37score
Recommendation
AVOID NEW MONEY

HUM

40score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric CVS HUM Winner
Forward P/E 10.6724 24.3309 CVS
PEG Ratio 0.2113 1.2545 CVS
Revenue Growth 7.1% 26.2% HUM
Earnings Growth 188.8% 27.1% CVS
Tradestie Score 37.4/100 40.0/100 HUM
Profit Margin 1.2% 0.9% CVS
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY AVOID NEW MONEY Tie

Relative Price Performance (Last 90 Days)

CVS 1M: +10.0% · 3M: -12.3% HUM 1M: +12.3% · 3M: +8.1%

Current Technical Phase

CVS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 62

RSI (14): 61.5 · Price: $94.48

HUM

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (2.7% over 20 days), RSI 56

RSI (14): 55.9 · Price: $420.97

Fundamentals Snapshot

Metric CVS HUM
Market Cap — —
Forward P/E 11.1 24.6
Trailing P/E 24.6 40.2
Revenue (TTM) — —
Revenue Growth 0.1% 0.3%
Gross Margin 0.1% 0.1%
Operating Margin 0.0% 0.0%
EPS 3.80 10.58
Dividend Yield 0.03% 0.01%

Frequently Asked Questions

Based on our detailed analysis, HUM is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.